Software and Services for Predictive Digital Twins in Biopharma Process Development and Manufacturing
Yokogawa Insilico Biotechnology GmbH
Stuttgart (Meitnerstraße 9) · Stuttgart (Löffelstr. 22-24) · Singapore · Boston, MANew on Amplifa
About Yokogawa Insilico Biotechnology
Yokogawa Insilico Biotechnology GmbH develops and supplies predictive digital twins for biopharmaceutical process development and manufacturing. The company, founded in Stuttgart in 2001, offers mechanistic models, customized software, and a high-performance computing platform for the simulation of living cells. Based on genome-based network models, customer data is integrated to create individualized network models with which the behavior of the respective production organism can be optimized. The product family Insilico Digital Twin Factory comprises modules for media optimization (Composer), feed strategy optimization (Feeder), and scale-up/scale-down prediction (Scaler); Insilico Advisor enables model-predictive monitoring of cell culture manufacturing. Customers are leading companies in the global biotechnology and pharmaceutical industries; the solutions are used as service projects or software applications, supplemented by training, consulting, and customer-specific software customization. Since 2022, the company has been a subsidiary of Yokogawa Electric Corporation (Tokyo).
- Site
- Stuttgart
- Processes
- Predictive digital twins for bioprocess development and manufacturing, Insilico Digital Twin Factory (Composer: media optimization, Feeder: feed strategy, Scaler:, Insilico Advisor (model-predictive monitoring), Mechanistic models and customized software, High-Performance Computing platform for cell simulation, Media optimization in bioprocess development, Clone analysis and clone selection, Metabolic simulations for metabolic engineering
- Materials
- Insilico Digital Twin Factory, Insilico Advisor, HPC Platform
- Certificates
- ISO 9001
- Founded
- 2001
- Employees
- 26
- Industries
- Biotechnology, Biopharma, Pharmaceutical Industry, Bioeconomy
- 01
Data capture and integration of the customer's bioprocess data
- 02
Reconstruction of genome-based network models
- 03
Model building and simulation on HPC platform
- 04
Software application or service project
- 05
Training, consulting, and customer-specific customization
Software Products and Methods
Insilico Digital Twin Factory
Platform for predictive biomanufacturing with the modules Composer (media optimization), Feeder (feed strategy), and Scaler (scale-up/down prediction).
Insilico Advisor
Software for model-predictive monitoring of cell culture manufacturing.
HPC Platform
High-Performance Computing platform for the simulation of living cells and metabolic networks.
Sites
Stuttgart (Meitnerstraße 9)
DEHeadquarters
Stuttgart (Löffelstr. 22-24)
DERegistered address
Singapore
SGBranch
Boston, MA
USBranch
Industries
Additional services
Reference customers
Quality
No published information or certifications on quality assurance are available.
| Evidence | Stuttgart |
|---|---|
| ISO 9001 |
Company History
- 2001
Foundation of Insilico Biotechnology in Stuttgart
- 2006
Registration of Insilico Biotechnology AG (Amtsgericht Stuttgart HRB 720911)
- 2015
Investment by MBG Mittelständische Beteiligungsgesellschaft Baden-Württemberg
- 2021
Acquisition by Yokogawa Electric Corporation
- 2022
Conversion to a GmbH and renaming to Yokogawa Insilico Biotechnology GmbH on 31.01.2022; release of the Insilico Digital Twin Factory and Pharma Innovation Award 2022
- 2025
Relocation of the registered address to Löffelstr. 22-24, 70597 Stuttgart